nd other types ofcancer. # # # The mission of the American Association for Cancer Research is toprevent and cure cancer. Founded in 1907 AACR is the world'soldest and largest professional organization dedicated to advancingcancer research. The membership includes nearly 26000 basictranslational and clinical researchers; health care professio
nd other types of
cancer.
# # #
The mission of the American Association for Cancer Research is to
prevent and cure cancer. Founded in 1907, AACR is the world's
oldest and largest professional organization dedicated to advancing
cancer research. The membership includes nearly 26,000 basic,
translational, and clinical researchers; health care professionals;
and cancer survivors and advocates in the United States and more
than 70 other countries. AACR marshals the full spectrum of
expertise from the cancer community to accelerate progress in the
prevention, diagnosis and treatment of cancer through high-quality
scientific and educational programs. It funds innovative,
meritorious research grants. The AACR Annual Meeting attracts more
than 17,000 participants who share the latest discoveries and
developments in the field. Special Conferences throughout the year
present novel data across a wide variety of topics in cancer
research, treatment, and patient care. AACR publishes five major
peer-reviewed journals: Cancer Research; Clinical Cancer Research;
Molecular Cancer Therapeutics; Molecular Cancer Research; and
Cancer Epidemiology, Biomarkers & Prevention. Its most recent
publication, CR, is a magazine for cancer survivors, patient
advocates, their families, physicians, and scientists. It provides
a forum for sharing essential, evidence-based information and
perspectives on progress in cancer research, survivorship, and
advocacy.
American Association for Cancer Research
615 Chestnut St., 17th Floor
Philadelphia, PA 19106-4404
Telephone: (215) 440-9300
Toll Free Telephone: 1-866-423-3965
Fax: (215) 440-7228
E-mail:
aacr@aacr.org '"/>Page: 1 2 3 Related medicine technology :1.
Genetic Analysis Systems Enter the Clinical Mainstream2.
Clinical Study Shows Regenecare Relieves Pain and Itching of Skin
Rashes Caused by Widely Used Cancer Drugs3.
Large Geographic Differences in EpiPen Prescriptions in the U.S.,
From the Journal of Allergy and Clinical Immunology4.
Clinical Data Suggest Decreased Bleeding Risk in People With Severe
Hemophilia A While Maintaining Factor VIII Levels Above One Percent5.
Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy
of BF-200 ALA In Actinic Keratosis6.
Halozyme Therapeutics Enhanze Technology Large Protein Molecule
Therapeutic Clinical Trial Results Presented at the 34th Annual
Meeting of the Controlled Release Society7.
Corgenix Reports New Clinical Data Correlating AtherOx Technology
With Vascular Disease8.
AVI BioPharma Partner Cook Medical Announces Completion of Patient
Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of
Cardiovascular Disease9.
Protox Announces Positive Clinical Data from Prostate Cancer Study10.
AM-Pharma Announces Positive Results of Phase IIa Clinical Trial
with Alkaline Phosphatase For Ulcerative Colitis11.
Cougar Biotechnology Announces Presentation of Positive CB7630
Clinical Data at ESMO Conference